Key Differences in TLR3/poly I:C Signaling and Cytokine Induction by Human Primary Cells: a Phenomenon Absent from Murine Cell Systems
Overview
Authors
Affiliations
TLR3 recognizes double-stranded RNA, a product associated with viral infections. Many details of TLR3-induced mechanisms have emerged from gene-targeted mice or inhibition studies in transformed cell lines. However, the pathways activated in human immune cells or cells from disease tissue are less well understood. We have investigated TLR3-induced mechanisms of human primary cells of the innate immune system, including dendritic cells (DCs), macrophages (MØs), endothelial cells (ECs), and synovial fibroblasts isolated from rheumatoid arthritis joint tissue (RA-SFs). Here, we report that while these cells all express TLR3, they differ substantially in their response to TLR3 stimulation. The key antiviral response chemokine IP-10 was produced by all cell types, while DCs and MØs failed to produce the proinflammatory cytokines TNFalpha and IL-6. Unexpectedly, TNFalpha was found secreted by TLR3-stimulated RA-SF. Furthermore, TLR3 stimulation did not activate NFkappaB, MAPKs, or IRF-3 in DCs and MØs, but was able to do so in ECs and RA-SF. These findings were specific for human cells, thereby revealing a complexity not previously expected. This is the first report of such cell type- and species-specific response for any TLR stimulation and helps to explain important difficulties in correlating murine models of inflammatory diseases and human inflammation.
Frameworks for transformational breakthroughs in RNA-based medicines.
Androsavich J Nat Rev Drug Discov. 2024; 23(6):421-444.
PMID: 38740953 DOI: 10.1038/s41573-024-00943-2.
Marton R, Sebok C, Mackei M, Traj P, Voroshazi J, Kemeny A PLoS One. 2024; 19(5):e0302913.
PMID: 38728358 PMC: 11086923. DOI: 10.1371/journal.pone.0302913.
Brain alarm by self-extracellular nucleic acids: from neuroinflammation to neurodegeneration.
Kunze R, Fischer S, Marti H, Preissner K J Biomed Sci. 2023; 30(1):64.
PMID: 37550658 PMC: 10405513. DOI: 10.1186/s12929-023-00954-y.
Subramaniam S, Ogoti Y, Hernandez I, Zogg M, Botros F, Burns R Blood Adv. 2021; 5(13):2760-2774.
PMID: 34242391 PMC: 8288670. DOI: 10.1182/bloodadvances.2021004360.
TLR3 agonists: RGC100, ARNAX, and poly-IC: a comparative review.
Komal A, Noreen M, El-Kott A Immunol Res. 2021; 69(4):312-322.
PMID: 34145551 PMC: 8213534. DOI: 10.1007/s12026-021-09203-6.